Literature DB >> 12054159

Changes in bone structure and mass with advancing age in the male C57BL/6J mouse.

Bernard P Halloran1, Virginia L Ferguson, Steven J Simske, Andrew Burghardt, Laura L Venton, Sharmila Majumdar.   

Abstract

To determine whether the mouse loses bone with aging and whether the changes mimic those observed in human aging, we examined the changes in the tibial metaphysis and diaphysis in the male C57BL/6J mouse over its life span using microcomputed tomography (microCT). Cancellous bone volume fraction (BV/TV) decreased 60% between 6 weeks and 24 months of age. Loss was characterized by decreased trabecular number (Tb.N), increased trabecular spacing (Tb.Sp), and decreased connectivity. Anisotropy decreased while the structure model index increased with age. Cortical bone thickness increased between 6 weeks and 6 months of age and then decreased continuously to 24 months (-12%). Cortical bone area (Ct.Ar) remained constant between 6 and 24 months. Fat-free weight reached a peak at 12 months and gradually declined to 24 months. Total mass lost between 12 and 24 months reached 10%. Overall, the age-related changes in skeletal mass and architecture in the mouse were remarkably similar to those seen in human aging. Furthermore, the rapid early loss of cancellous bone suggests that bone loss is not just associated with old age in the mouse but rather occurs as a continuum from early growth. We conclude that the C57BL/6J male mouse maybe a useful model to study at least some aspects of age-related bone loss in humans.

Entities:  

Keywords:  Non-programmatic

Mesh:

Year:  2002        PMID: 12054159     DOI: 10.1359/jbmr.2002.17.6.1044

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  111 in total

1.  Deficiency of circadian clock protein BMAL1 in mice results in a low bone mass phenotype.

Authors:  William E Samsa; Amit Vasanji; Ronald J Midura; Roman V Kondratov
Journal:  Bone       Date:  2016-01-14       Impact factor: 4.398

2.  Inhibition of CaMKK2 reverses age-associated decline in bone mass.

Authors:  Zachary J Pritchard; Rachel L Cary; Chang Yang; Deborah V Novack; Michael J Voor; Uma Sankar
Journal:  Bone       Date:  2015-02-25       Impact factor: 4.398

3.  Quantification of trabecular bone structure using magnetic resonance imaging at 3 Tesla--calibration studies using microcomputed tomography as a standard of reference.

Authors:  C A Sell; J N Masi; A Burghardt; D Newitt; T M Link; S Majumdar
Journal:  Calcif Tissue Int       Date:  2005-05-05       Impact factor: 4.333

Review 4.  Current technologies in the evaluation of bone architecture.

Authors:  Sharmila Majumdar
Journal:  Curr Osteoporos Rep       Date:  2003-12       Impact factor: 5.096

Review 5.  Current diagnostic techniques in the evaluation of bone architecture.

Authors:  Thomas M Link; Sharmila Majumdar
Journal:  Curr Osteoporos Rep       Date:  2004-06       Impact factor: 5.096

6.  32 wk old C3H/HeJ mice actively respond to mechanical loading.

Authors:  Sandra L Poliachik; DeWayne Threet; Sundar Srinivasan; Ted S Gross
Journal:  Bone       Date:  2008-01-15       Impact factor: 4.398

7.  Kynurenine, a Tryptophan Metabolite That Accumulates With Age, Induces Bone Loss.

Authors:  Mona El Refaey; Meghan E McGee-Lawrence; Sadanand Fulzele; Eileen J Kennedy; Wendy B Bollag; Mohammed Elsalanty; Qing Zhong; Ke-Hong Ding; Nathaniel G Bendzunas; Xing-Ming Shi; Jianrui Xu; William D Hill; Maribeth H Johnson; Monte Hunter; Jessica L Pierce; Kanglun Yu; Mark W Hamrick; Carlos M Isales
Journal:  J Bone Miner Res       Date:  2017-08-14       Impact factor: 6.741

8.  Chronic kidney disease and aging differentially diminish bone material and microarchitecture in C57Bl/6 mice.

Authors:  Chelsea M Heveran; Charles A Schurman; Claire Acevedo; Eric W Livingston; Danielle Howe; Eric G Schaible; Heather B Hunt; Adam Rauff; Eve Donnelly; R Dana Carpenter; Moshe Levi; Anthony G Lau; Ted A Bateman; Tamara Alliston; Karen B King; Virginia L Ferguson
Journal:  Bone       Date:  2019-05-02       Impact factor: 4.398

9.  Mutation in osteoactivin decreases bone formation in vivo and osteoblast differentiation in vitro.

Authors:  Samir M Abdelmagid; Joyce Y Belcher; Fouad M Moussa; Suzanne L Lababidi; Gregory R Sondag; Kimberly M Novak; Afif S Sanyurah; Nagat A Frara; Roshanak Razmpour; Fabiola E Del Carpio-Cano; Fayez F Safadi
Journal:  Am J Pathol       Date:  2014-01-23       Impact factor: 4.307

Review 10.  From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis.

Authors:  Stavros C Manolagas
Journal:  Endocr Rev       Date:  2010-01-05       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.